Clinical trial
Safety and Efficacy of RK0202 in Oral Mucositis
NCT00230191 · RxKinetix, Industry · Completed
Key facts
| NCT number | NCT00230191 |
|---|---|
| Title | Safety and Efficacy of RK0202 in Oral Mucositis |
| Official title | Phase II, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of the Effects of RK-0202 on Oral Mucositis in Patients Receiving Radiation Therapy for Tumors of the Oral Cavity, Oropharynx, Nasopharynx, Salivary Glands or Supraglottic Region |
| Lead sponsor | RxKinetix, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mouth Diseases, Mouth Ulcers, Oral Mucositis, Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | RK-0202 |
| Enrollment | 110 |
| Start date | Jan 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Sep 30, 2005 |
| Last update posted | Jan 15, 2007 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: